Association of frailty-risk indicators with cardiovascular diseases: evidence from the CHARLS

Fangfang Zhuo1,2, Zhao' Xing Cao2,3, Zhipeng Pu1,2

  • 1Guizhou Medical University, Guiyang, Guizhou, 550004, China.

Insights

Frailty risk factors, including handgrip strength and cystatin C, are associated with cardiovascular diseases (CVDs). Incorporating these indicators can improve CVD risk assessment and prevention strategies.

Area of Science:

  • Gerontology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular diseases (CVDs) represent a significant global health burden, with China experiencing escalating healthcare costs.
  • Frailty, a state of reduced physiological reserve, is linked to aging and increased health risks.
  • Existing frailty assessments may not be fully applicable using available data, necessitating the use of "frailty risk factors".

Purpose of the Study:

  • To investigate the association between specific frailty risk factors and the prevalence of cardiovascular diseases (CVDs) in a Chinese population.
  • To evaluate the predictive performance of machine learning models for CVD risk stratification using these factors.
  • To identify key frailty-related indicators that contribute to CVD risk.

Main Methods:

  • Analysis of data from the 2015 China Health and Retirement Longitudinal Study (CHARLS) involving 10,657 participants.
  • Utilized LASSO regression for variable selection, followed by logistic regression and machine learning models (LR, XGBoost, LightGBM, SVM, RF, DT).
  • Model performance assessed through discrimination, calibration, decision curve analysis, and SHAP interpretability.

Main Results:

  • The XGBoost model demonstrated superior performance in predicting CVDs.
  • Key predictors of increased CVD risk included age, HbA1c, uric acid (UA), and cystatin C (Cys C).
  • Higher handgrip strength (HGS)/weight ratio and lower blood pressure were associated with reduced CVD risk.

Conclusions:

  • Frailty risk factors, particularly HGS/weight ratio and Cys C, offer valuable insights for CVD risk stratification beyond traditional markers.
  • Simple physical performance assessments and frailty risk evaluations can enhance current CVD prevention strategies.
  • Integrating these measures into clinical practice may improve early detection and management of cardiovascular disease.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...